因?yàn)?/c>這可能有利于哥倫比亞的提案。
Lance Armstrong said, also that he only used a little bit of EPO previously.
蘭斯阿姆斯特朗表示，還說他之前只服用過一點(diǎn)點(diǎn)EPO。
The stimulating effect of recombinant-erythropoietin (EPO-A) on erythropoiesis has raised interest in its administration as an alternative.
因而重組促紅細(xì)胞生成素對(duì)紅細(xì)胞生成的刺激作用作為一種替代方法引起了人們的關(guān)注。
The Licensee agrees to allow access to a sample of its Products to the EPO solely for monitoring purposes, at no cost to the EPO.
被許可方同意允許歐洲專利局為了監(jiān)控的目的免費(fèi)訪問其產(chǎn)品樣品。
The researchers injected mice with EPO every other day for three weeks to test the long-term impact of the drug.
研究人員在三周時(shí)間里每隔一天給老鼠注射促紅細(xì)胞生成素，以檢測(cè)藥物的長(zhǎng)期影響。
Today, anyone wishing to register a patent must do so in one of the EPO's official languages - English, French and German.
目前，任何人想要注冊(cè)專利，必須使用EPO的官方語(yǔ)言之一，即英文、法文或德文。
Studies have found that EPO receptor is widely distributed in a variety of non-hematopoietic tissue, including myocardial tissue.
研究發(fā)現(xiàn)EPO受體廣泛分布于各種非造血組織，其中包括心臟組織。
His body has a mutation that causes it to produce far more of a hormone called EPO than a normal person would.
由于他的身體的某些基因發(fā)生突變，導(dǎo)致其身體產(chǎn)生了超出常人正常量的一種名為EPO的荷爾蒙。
Conclusion Traditional medicine compound can improve anemia symptum of rat. Chronic adynamia could promote creation of EPO as well.
驗(yàn)證了中藥復(fù)方可以改善慢性腎衰大鼠貧血狀態(tài)，促進(jìn)EPO生成。
The Licensee is not permitted to copy an EPO data carrier using all data, data structure and software as sent to the Licensee by the EPO.
被許可方不得復(fù)制使用歐洲專利局送交被許可方的數(shù)據(jù)、數(shù)據(jù)結(jié)構(gòu)和軟件的歐洲專利局數(shù)據(jù)載體。
The discovery of the great neuroprotective potential of EPO has opened a new therapy for diseases in nervous system.
促紅細(xì)胞生成素強(qiáng)大神經(jīng)保護(hù)潛力的發(fā)現(xiàn)，開辟了神經(jīng)系統(tǒng)疾病新的治療途徑。
Continuous erythropoietin receptor activator(CERA) is a third-generation erythropoiesis-stimulating agents(ESA).
持續(xù)型EPO受體激活劑（CERA）是新出現(xiàn)的一種第三代紅細(xì)胞生成刺激劑（ESA）。
However, the mechanism of this effect is still unclear.
但目前EPO抗炎癥作用相關(guān)的機(jī)制尚不明確。
Authors analysed concentration of erythropoietin (EPO) in fetal blood from pregnancies complicated by serologic conflict.
作者分析了濃度的紅細(xì)胞生成素（EPO）在胎血從懷孕復(fù)雜血清沖突。
They demonstrated outside the European Patent Office (EPO) in Munich on Wednesday, on the eve of a deadline for objections to the patent.
在專利權(quán)的最后期限的前夜，即周三，他們在慕尼黑歐洲專利局外進(jìn)行示威抗議。
The Official Journal of the European Patent Office is a monthly trilingual publication of the European Patent Office (EPO).
歐洲專利公報(bào)局是歐洲專利局每月三語(yǔ)出版的一本期刊。
BMP could treat and repair hematopoietic injury, whose function of inducing hematopoiesis was obviously superior to CSF, EPO and TPO.
在惡性腫瘤放療和化學(xué)藥物治療中，許多病人都是因造血系統(tǒng)的損傷，無(wú)法完成治療過程而喪夫生命。
The method of measuring EPO is determined based on the concept of environmental value chain and the principle of measuring EPO.
基于環(huán)境價(jià)值鏈概念和環(huán)境績(jī)效評(píng)估原則探討了環(huán)境績(jī)效評(píng)估方法的選用。
A copy of a EPO data carrier is not a Product according to this Agreement.
EPO數(shù)據(jù)載體副本不屬于本協(xié)議項(xiàng)下的產(chǎn)品。
The EPO and Google have today signed a Memorandum of Understanding to improve access to patent translations in multiple languages.
歐洲專利局（EPO）與谷歌（Google）于11月30日簽署了一份諒解備忘錄，旨在改善專利的多語(yǔ)言翻譯。
French anti-doping organizations Pierre said they suspect some drivers used the CERA (EPO third-generation products).
法國(guó)反興奮劑組織負(fù)責(zé)人皮埃爾稱，他們懷疑還有一些車手使用了CERA（EPO的第三代產(chǎn)品）。
Like EPO, vascular endothelial growth factor spurs red-blood-cell formation and thus helps to supply tissues with oxygen.
跟EPO一樣，血管內(nèi)皮生長(zhǎng)因子促使紅細(xì)胞的形成從而幫助組織供血。
The EPO thought the report made some interesting suggestions for an alternative and more promising approach.
歐洲專利局認(rèn)為，報(bào)告對(duì)另外一種更有前途的方法提出了有趣的建議。
Apart from the red cell surface, erythropoietin 's receptor (Epo-R) is also expressed in a large variety of normal tissues.
促紅細(xì)胞生成素的受體除分布在紅血球表面外，也在大批正常組織表達(dá)。
The EPO shall take all reasonable steps to avoid the inclusion of such non-conforming data.
歐洲專利局應(yīng)當(dāng)采取一切合理的措施，避免包含上述不符合要求的數(shù)據(jù)。
Objective: To investigate in vitro release characteristics of collagen double layer minipellet of erythropoietin(EPO).
目的：對(duì)紅細(xì)胞生成素膠原蛋白雙層微條的體外釋放特性進(jìn)行研究。
EPO is a natural hormone that stimulates production of the Hb-containing red blood cells.
促紅細(xì)胞生成素是一種天然的激素，可以促進(jìn)含血紅蛋白的紅細(xì)胞的生成。
The IOC Medical Commission has approved a test to detect the use of the banned synthetic hormone erythropoietin, or EPO.
國(guó)際奧委會(huì)藥物委員會(huì)已經(jīng)通過了一項(xiàng)測(cè)試來(lái)檢測(cè)違禁使用合成激素紅細(xì)胞生成素（簡(jiǎn)稱EPO）的情況。
The invention discloses a blood brain barrier penetrable erythropoietin (EPO) which belongs to the field of biological pharmacy.
本發(fā)明公開了一種血腦屏障穿透性促紅細(xì)胞生成素，屬于生物制藥領(lǐng)域。
Emphasis should be put on alkali rich porphyry outcropping area in the east of Bengge to explore the gold deposit of Himalaya epo. . .
尋找喜馬拉雅期金礦床，重點(diǎn)應(yīng)放在甭哥以東的富堿斑巖出露區(qū)。
The EPO has its headquarters in Munich, a branch in The Hague, and sub-offices in Berlin and Vienna.
歐洲專利局總部設(shè)在慕尼黑，一個(gè)分支在海牙，分辦事處在柏林和維也納。
The most frequent causes of PTA were erythropoietin (EPO) and iron deficiency.
導(dǎo)致PTA最常見的原因是紅細(xì)胞生成素（EPO）和缺鐵。
The EPO has only three official languages: English, French and German.
歐洲專利局的官方語(yǔ)言只有英語(yǔ)，法語(yǔ)及德語(yǔ)。
The existing evidence on the early use of EPO-A in the acute phase of trauma patients management consists of only 14 publications.
關(guān)于促紅細(xì)胞生成素-A（EPO-A）應(yīng)用于創(chuàng)傷患者治療急性期的現(xiàn)存臨床證據(jù)僅14篇已發(fā)表文獻(xiàn)。
An EPO detection test, based on a combination of blood and urine analysis, was first implemented at the Sydney Olympic Games in 2000.
對(duì)EPO的檢測(cè)建立在對(duì)血和尿液進(jìn)行聯(lián)合分析的基礎(chǔ)上，2000年的悉尼奧運(yùn)會(huì)上第一次實(shí)行了這種檢測(cè)。
The EPO collects bibliographic data from over 70 countries and legal status data from more than 40 patent authorities.
EPO從70個(gè)國(guó)家收集書目數(shù)據(jù)，并且從超過40個(gè)專利當(dāng)局收集法律數(shù)據(jù)。
Conclusion: The release of EPO from double layer minipellet . . .
結(jié)論：雙層微條的釋放平穩(wěn)，具有顯著的緩釋效果。
Nor may the Licensee pass on EPO data to third parties for such purposes.
被許可方也不得為了上述目的將EPO局數(shù)據(jù)交付給任何第三方。
The EPO may make exceptions from this provision by written consent to the Licensee.
歐洲專利局可通過書面同意的形式，對(duì)上述規(guī)定作出例外。
英 
